ReviewJournal of neuro-oncology2014
Imaging guidelines and findings of extracranial glioblastoma.
Review in Journal of neuro-oncology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
14 citing papers in PubMed, 29 citations in OpenAlex.
- Beyond the Typical Atypical Imaging Features of Leptomeningeal Enhancement: A Case Series.Brain sciences · 2026Article
- Clinical, radiological, and molecular insights into extracranial metastases from adult gliomas.Neuro-oncology · 2026Article
- Nanoparticle-Based Approaches for Glioblastoma Treatment: Advances and Future Prospects.CNS & neurological disorders drug targets · 2026Review
- Glioblastoma-A Contemporary Overview of Epidemiology, Classification, Pathogenesis, Diagnosis, and Treatment: A Review Article.International journal of molecular sciences · 2025Review
- Glioblastoma mimicking autoimmune meningitis in an adult: A complex diagnostic challenge.Surgical neurology international · 2025Article
- Clinical Reasoning: A 63-Year-Old Man With Progressive Multicranial Neuropathy and Leptomeningeal Enhancement.Neurology · 2024Article
- Article
- Article
- Natural history of spinal cord metastasis from brain glioblastomas.Journal of neuro-oncology · 2023Article
- A Retrospective Study on Spinal Dissemination of Supratentorial Glioma.Frontiers in oncology · 2021Article
- Leptomeningeal Spread in Glioblastoma: Diagnostic and Therapeutic Challenges.The oncologist · 2020Review
- Secondary glioblastoma with abdominal metastasis: Case report.Radiology case reports · 2018Article
- Cervical spinal glioblastoma multiforme in the elderly.BMJ case reports · 2017Article
- Extensive epidural extension growth of a glioblastoma: a case report and literature review.International journal of clinical and experimental medicine · 2015Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Extracranial manifestations of glioblastoma are uncommon and include a wide spectrum of entities, such as primary spinal cord glioblastoma, spinal leptomeningeal metastasis, seeding into the scalp following intracranial glioblastoma resection, direct extension of an intracranial glioblastoma though a craniotomy defect, dissemination via shunt catheter, and systemic metastasis, including lymphatic and hematogenous spread. Imaging plays an important role in the management of patients with extracranial glioblastomas and guidelines for the imaging evaluation of these lesions are reviewed. For example, MRI is the modality of choice for evaluating glioblastoma involving the scalp and spine. In particular, advanced imaging techniques such as MR spectroscopy, MR perfusion, diffusion-weighted imaging, and diffusion-tensor imaging can be useful for early detection and characterization of these lesions. CT and (18)FDG-PET are suitable modalities for evaluating systemic and CSF shunt-related metastases.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.